Listen to the article
Royal Health Rumors Debunked: No Evidence King Charles Has Rare Disease
Unfounded claims circulating online that King Charles III is “dying of Kuru” after alleged “child meat banquets” have been thoroughly debunked by fact-checkers. These baseless allegations, which appeared in a video posted to social media on April 28, 2026, represent the latest in a stream of misinformation targeting the British monarch.
The video, shared by an X (formerly Twitter) account, makes the extraordinary claim that King Charles has been diagnosed with Kuru—a rare and fatal prion disease historically linked to cannibalism practices among the Fore people of Papua New Guinea. The condition is caused by consuming infected human brain tissue.
The post further alleges connections between King Charles and convicted sex offender Jeffrey Epstein, suggesting “highly redacted links” exist between the two and that “the walls are closing in” on the monarch. The video offers no credible evidence or sources to support these sensational claims.
An extensive search through U.S. Department of Justice Epstein files revealed multiple documents mentioning Prince Charles, but none containing the alleged “redacted links” referenced in the video. These allegations appear to be entirely fabricated.
While King Charles has publicly announced a cancer diagnosis, there is no credible medical information suggesting he has been diagnosed with Kuru or any prion disease. Royal health announcements typically come through official channels and are reported by established news organizations, not fringe websites known for publishing fabricated content.
The source of these unfounded rumors, The People’s Voice, has a well-documented history of spreading misinformation. The website has undergone multiple rebrands, previously operating as YourNewsWire (founded in 2014) and later as NewsPunch (2017) before adopting its current name in 2023. Media watchdogs have consistently identified it as one of the most prolific publishers of fake news online.
The site’s modus operandi typically involves creating sensational headlines unsupported by credible sources, fabricating quotes, and misrepresenting scientific research. In 2018, the site’s Facebook page lost its verification status following concerns about the accuracy of its content, according to reporting by Media Matters for America.
Health misinformation experts note that false claims about public figures’ medical conditions are particularly common forms of disinformation. These rumors can spread rapidly through social media channels where emotional, shocking content tends to generate significant engagement regardless of accuracy.
The royal family has been a frequent target of conspiracy theories and misinformation, with false narratives often gaining traction during periods of public interest in the monarchy’s affairs. King Charles’ actual cancer diagnosis, which he disclosed earlier this year, has unfortunately created an opportunity for purveyors of misinformation to exploit public concern about his health.
Medical experts emphasize that Kuru is an extremely rare condition that has been virtually eliminated globally since the cessation of the specific cultural practices that spread it. The disease has distinctive symptoms that would be impossible to conceal in a public figure under constant medical care and media scrutiny.
This incident serves as a reminder for media consumers to exercise critical thinking when encountering extraordinary claims online, particularly those without credible sourcing or evidence. Health and medical information about public figures should be verified through official channels and reputable news organizations before being accepted as factual.
The British royal family has not commented on these specific allegations, consistent with their general practice of not addressing baseless conspiracy theories that circulate about the monarchy.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


25 Comments
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Uranium names keep pushing higher—supply still tight into 2026.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Fact Check might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.